1 (2,4 difluorophenyl) ,2-(1,2,4-triazol-1-yl)ethanone CAS:86404-63-9

In the pharmaceutical industry, it has been explored as a lead compound for the development of novel drugs targeting various diseases, including cancer and infectious diseases. Its ability to inhibit key enzymes and disrupt disease-related pathways makes it an attractive candidate for further drug development. In addition to its pharmaceutical applications, it has also been studied for its use as a fluorescent probe due to its unique spectral properties, which make it useful for imaging and diagnostic purposes.